Chemical Process R&D, Discovery Process Research, Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340, Beerse, Belgium.
Université de Rennes, CNRS, ISCR-UMR6226, Rennes, 35000, France.
Chemistry. 2022 Jun 27;28(36):e202201078. doi: 10.1002/chem.202201078. Epub 2022 May 12.
Direct reductive amination (DRA) is a ubiquitous reaction in organic chemistry. This transformation between a carbonyl group and an amine is most often achieved by using a super stoichiometric amount of hazardous hydride reagents, thus being incompatible with many sensitive functional groups. DRA could also be achieved by means of chemo- or biocatalysis, thereby attracting the interest of industry as well as academic laboratories due to the virtually perfect atom economy. Although DRAs are well-established for substrate pairs such as aldehydes with either 1° or 2° amines as well as ketones with 1° amines, the current methodologies are limited in the case of ketones with 2° amines. Herein, we present a general DRA protocol that overcomes this major limitation by means of iridium catalysis. The applicability of the methodology is demonstrated by accessing an unprecedented range of biologically relevant tertiary amines starting from both aliphatic ketones and aliphatic amines. The choice of a disphosphane ligand (Josiphos A or Xantphos) is essential for the success of the transformation.
直接还原胺化(DRA)是有机化学中普遍存在的反应。羰基和胺之间的这种转化最常通过使用超化学计量的危险氢化物试剂来实现,因此与许多敏感官能团不兼容。DRA 也可以通过化学或生物催化来实现,因此由于几乎完美的原子经济性,它引起了工业界和学术实验室的兴趣。尽管 DRA 已经在醛与 1°或 2°胺以及酮与 1°胺等底物对中得到很好的建立,但目前的方法在酮与 2°胺的情况下受到限制。在此,我们提出了一种通用的 DRA 方案,通过铱催化克服了这一主要限制。该方法的适用性通过从脂肪族酮和脂肪族胺开始获得前所未有的一系列生物相关的叔胺来证明。双膦配体(Josiphos A 或 Xantphos)的选择对于转化的成功至关重要。